Paper2425199
Recurrence and survival after total mesorectal excision for rectal cancer.
Heald RJ and 1 other. Lancet, 1986. Cited by 2,112 papers, by iCite.
Cite this record
ConductScience Library. Recurrence and survival after total mesorectal excision for rectal cancer. Papers, record 2425199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2425199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rectal Neoplasms | Major topic |
| Rectum | Major topic |
| Follow-Up Studies | |
| Humans | |
| Methods | |
| Neoplasm Recurrence, Local | |
| Neoplasm Staging | |
| Palliative Care | |
| Postoperative Complications | |
| Surgical Staplers |
Source PubMed
Trials11
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00855946 | Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy | Background | ClinicalTrials.gov | |
| NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | Background | ClinicalTrials.gov | |
| NCT02843191 | Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy | Background | ClinicalTrials.gov | |
| NCT02943694 | The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer | Background | ClinicalTrials.gov | |
| NCT02954913 | Simultaneous Resection of Colorectal Cancer With Synchronous Liver Metastases | Background | ClinicalTrials.gov | |
| NCT03351959 | Complete Pathologic Response Rectal Cancers | Background | ClinicalTrials.gov | |
| NCT03895255 | Selective sPlenic flExure Mobilization for Low colorEctal Anastomosis After D3 lYmph Node Dissection (Speedy Trial) | Results | ClinicalTrials.gov | |
| NCT04134104 | Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy | Background | ClinicalTrials.gov | |
| NCT04200027 | Robotic vs. TaTME Rectal Surgery (ROTA STUDY) | Background | ClinicalTrials.gov | |
| NCT05136326 | Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer | Background | ClinicalTrials.gov | |
| NCT07404228 | Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment | Background | ClinicalTrials.gov |
Cited by870
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42875765 | Routine versus postoperative CRP/CT guided selective diverting ileostomy after laparoscopic low anterior resection for rectal cancer: a comparative randomized controlled trial. | BMC Surg | 2026 | https://conductscience.org/library/papers/42875765 | PubMed |
| 42834699 | A systematic review and meta-analysis of preoperative MRI-based pelvimetry in predicting surgical difficulty in rectal cancer: Implications for personalised surgical planning. | Colorectal Dis | 2026 | https://conductscience.org/library/papers/42834699 | PubMed |
| 42720902 | Nonlinear association between number of lymph nodes resected and survival in T1N0M0 colorectal cancer: a SEER-based analysis. | Updates Surg | 2026 | https://conductscience.org/library/papers/42720902 | PubMed |
| 42704036 | The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review. | Radiol Oncol | 2026 | https://conductscience.org/library/papers/42704036 | PubMed |
| 42698441 | Deep learning-assisted near-real-time identification of the inferior mesenteric artery and vein during laparoscopic rectal resection: a single-center proof-of-concept study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42698441 | PubMed |
| 42682280 | Artificial intelligence real-time overall recognition model for total mesorectal excision. | Int J Surg | 2026 | https://conductscience.org/library/papers/42682280 | PubMed |
| 42621528 | Synchronous Nasopharyngeal Carcinoma and Rectal Adenocarcinoma Treated With Integrated Multimodal Therapy: A Case Report and Literature Review. | Cureus | 2026 | https://conductscience.org/library/papers/42621528 | PubMed |
| 42477736 | Advances in predictive factors for pathological complete response after neoadjuvant therapy in locally advanced rectal cancer. | Radiat Oncol | 2026 | https://conductscience.org/library/papers/42477736 | PubMed |
| 42441088 | Efficacy of adjuvant chemotherapy in patients with late-onset stage II/III colon cancer: a retrospective cohort study. | Open Med (Wars) | 2026 | https://conductscience.org/library/papers/42441088 | PubMed |
| 42437419 | Digital rectal examination in rectal cancer response assessment: clinical performance and the need for standardized reporting. | Tech Coloproctol | 2026 | https://conductscience.org/library/papers/42437419 | PubMed |
| 42396616 | Rethinking lymphadenectomy in the immunotherapy era of colorectal cancer: A hypothesis-generating perspective. | Colorectal Dis | 2026 | https://conductscience.org/library/papers/42396616 | PubMed |
| 42360525 | Predicting anatomical difficulty in robot-assisted rectal resection using a novel anatomic landmark-based grading system: a prospective observational study. | Tech Coloproctol | 2026 | https://conductscience.org/library/papers/42360525 | PubMed |
| 42307785 | Tumor regression pattern and distribution of residual tumor cells in potential candidates for local excision of rectal cancer: a prospective cohort study. | Tech Coloproctol | 2026 | https://conductscience.org/library/papers/42307785 | PubMed |
| 42266123 | Margin-driven outcomes prevail over resection planes: multivisceral surgery matches total mesorectal excision in locally advanced rectal cancer. | Ann Coloproctol | 2026 | https://conductscience.org/library/papers/42266123 | PubMed |
| 42255982 | MESORECT : Influence of bladder depletion on mesorectal movements during radiation therapy of locally advanced rectal cancers: a prospective comparative study. | Clin Transl Radiat Oncol | 2026 | https://conductscience.org/library/papers/42255982 | PubMed |
| 42223567 | Resection quality and oncologic outcomes after robotic versus laparoscopic total mesorectal excision for mid and low rectal cancer: a systematic review and meta-analysis of randomised trials. | J Robot Surg | 2026 | https://conductscience.org/library/papers/42223567 | PubMed |
| 42206822 | Short-term outcomes in robotic-assisted versus conventional laparoscopic surgery for rectal cancer: population-based study. | BJS Open | 2026 | https://conductscience.org/library/papers/42206822 | PubMed |
| 42199895 | The right hemicolon fascial system: a narrative review. | Front Surg | 2026 | https://conductscience.org/library/papers/42199895 | PubMed |
| 42187894 | Total Neoadjuvant Therapy, Organ Preservation and Beyond: A State-of-the-Art Systematic Review and Critical Appraisal of Locally Advanced Rectal Cancer Management. | Diseases | 2026 | https://conductscience.org/library/papers/42187894 | PubMed |
| 42121646 | Quality of Life and Functional Outcomes After Rectal Cancer Surgery: A Comparative Study Applying EORTC QLQ-C30, QLQ-CR29, and LARS Score at 1-6 Months Postoperatively. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42121646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2425199
GET https://conductscience.org/api/papers/v1/2425199/cited_by?page=2